CHIMERA INVESTMENT CORP - CIM 8 7/8 08/15/30 (CIMP) Fundamental Analysis & Valuation

NYSE:CIMP • US16934Q8693

Current stock price

24.88 USD
-0.1 (-0.4%)
Last:

This CIMP fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

4

1. CIMP Profitability Analysis

1.1 Basic Checks

  • In the past year CIMP was profitable.
  • CIMP had a negative operating cash flow in the past year.
  • Of the past 5 years CIMP 4 years were profitable.
  • Of the past 5 years CIMP 4 years had a positive operating cash flow.
CIMP Yearly Net Income VS EBIT VS OCF VS FCFCIMP Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 200M -200M 400M -400M 600M

1.2 Ratios

  • With a decent Return On Assets value of 0.91%, CIMP is doing good in the industry, outperforming 61.76% of the companies in the same industry.
  • CIMP's Return On Equity of 5.62% is in line compared to the rest of the industry. CIMP outperforms 54.41% of its industry peers.
  • CIMP has a Return On Invested Capital (0.68%) which is comparable to the rest of the industry.
  • Measured over the past 3 years, the Average Return On Invested Capital for CIMP is in line with the industry average of 1.41%.
Industry RankSector Rank
ROA 0.91%
ROE 5.62%
ROIC 0.68%
ROA(3y)0.67%
ROA(5y)0.3%
ROE(3y)3.75%
ROE(5y)1.04%
ROIC(3y)0.82%
ROIC(5y)1.32%
CIMP Yearly ROA, ROE, ROICCIMP Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 10 -10 -20

1.3 Margins

  • CIMP has a better Profit Margin (18.10%) than 69.12% of its industry peers.
  • CIMP's Profit Margin has improved in the last couple of years.
  • Looking at the Operating Margin, with a value of 15.62%, CIMP is in line with its industry, outperforming 54.41% of the companies in the same industry.
  • In the last couple of years the Operating Margin of CIMP has declined.
  • CIMP has a Gross Margin (31.43%) which is comparable to the rest of the industry.
  • CIMP's Gross Margin has declined in the last couple of years.
Industry RankSector Rank
OM 15.62%
PM (TTM) 18.1%
GM 31.43%
OM growth 3Y-22.61%
OM growth 5Y-19.82%
PM growth 3YN/A
PM growth 5Y70.35%
GM growth 3Y-12.54%
GM growth 5Y-10.18%
CIMP Yearly Profit, Operating, Gross MarginsCIMP Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 50 -50

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

0

2. CIMP Health Analysis

2.1 Basic Checks

  • The Return on Invested Capital (ROIC) is below the Cost of Capital (WACC), so CIMP is destroying value.
  • CIMP has more shares outstanding than it did 1 year ago.
  • CIMP has more shares outstanding than it did 5 years ago.
  • CIMP has a worse debt/assets ratio than last year.
CIMP Yearly Shares OutstandingCIMP Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 20M 40M 60M 80M
CIMP Yearly Total Debt VS Total AssetsCIMP Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 5B 10B 15B 20B 25B

2.2 Solvency

  • CIMP has an Altman-Z score of -0.54. This is a bad value and indicates that CIMP is not financially healthy and even has some risk of bankruptcy.
  • CIMP has a Altman-Z score of -0.54. This is in the lower half of the industry: CIMP underperforms 61.76% of its industry peers.
  • A Debt/Equity ratio of 4.62 is on the high side and indicates that CIMP has dependencies on debt financing.
  • Looking at the Debt to Equity ratio, with a value of 4.62, CIMP is in the better half of the industry, outperforming 60.29% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 4.62
Debt/FCF N/A
Altman-Z -0.54
ROIC/WACC0.14
WACC5.03%
CIMP Yearly LT Debt VS Equity VS FCFCIMP Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 2B 4B 6B 8B

2.3 Liquidity

  • CIMP has a Current Ratio of 0.05. This is a bad value and indicates that CIMP is not financially healthy enough and could expect problems in meeting its short term obligations.
  • CIMP has a worse Current ratio (0.05) than 75.00% of its industry peers.
  • CIMP has a Quick Ratio of 0.05. This is a bad value and indicates that CIMP is not financially healthy enough and could expect problems in meeting its short term obligations.
  • CIMP has a worse Quick ratio (0.05) than 75.00% of its industry peers.
Industry RankSector Rank
Current Ratio 0.05
Quick Ratio 0.05
CIMP Yearly Current Assets VS Current LiabilitesCIMP Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 5B 10B 15B

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

5

3. CIMP Growth Analysis

3.1 Past

  • The Earnings Per Share has grown by an nice 16.44% over the past year.
  • Measured over the past years, CIMP shows a very negative growth in Earnings Per Share. The EPS has been decreasing by -17.80% on average per year.
  • The Revenue has been growing slightly by 5.61% in the past year.
  • Measured over the past years, CIMP shows a decrease in Revenue. The Revenue has been decreasing by -7.79% on average per year.
EPS 1Y (TTM)16.44%
EPS 3Y-19.34%
EPS 5Y-17.8%
EPS Q2Q%43.24%
Revenue 1Y (TTM)5.61%
Revenue growth 3Y4.64%
Revenue growth 5Y-7.79%
Sales Q2Q%-65.33%

3.2 Future

  • The Earnings Per Share is expected to grow by 12.76% on average over the next years. This is quite good.
  • CIMP is expected to show quite a strong growth in Revenue. In the coming years, the Revenue will grow by 9.33% yearly.
EPS Next Y19.71%
EPS Next 2Y12.76%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year15.32%
Revenue Next 2Y9.33%
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

  • The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
  • The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
CIMP Yearly Revenue VS EstimatesCIMP Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 200M 400M 600M 800M 1B
CIMP Yearly EPS VS EstimatesCIMP Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2 4 6

More info and screens

Find the best growth stocksShow best growing peers

4

4. CIMP Valuation Analysis

4.1 Price/Earnings Ratio

  • CIMP is valuated correctly with a Price/Earnings ratio of 14.64.
  • The rest of the industry has a similar Price/Earnings ratio as CIMP.
  • CIMP is valuated rather cheaply when we compare the Price/Earnings ratio to 25.70, which is the current average of the S&P500 Index.
  • The Price/Forward Earnings ratio is 12.23, which indicates a correct valuation of CIMP.
  • CIMP's Price/Forward Earnings ratio is in line with the industry average.
  • CIMP's Price/Forward Earnings ratio indicates a valuation a bit cheaper than the S&P500 average which is at 23.84.
Industry RankSector Rank
PE 14.64
Fwd PE 12.23
CIMP Price Earnings VS Forward Price EarningsCIMP Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 20 40 60 80

4.2 Price Multiples

  • CIMP's Enterprise Value to EBITDA ratio is a bit cheaper when compared to the industry. CIMP is cheaper than 73.53% of the companies in the same industry.
Industry RankSector Rank
P/FCF N/A
EV/EBITDA 67.08
CIMP Per share dataCIMP EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 10 20 30

4.3 Compensation for Growth

  • The low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
  • A more expensive valuation may be justified as CIMP's earnings are expected to grow with 12.76% in the coming years.
PEG (NY)0.74
PEG (5Y)N/A
EPS Next 2Y12.76%
EPS Next 3YN/A

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

3

5. CIMP Dividend Analysis

5.1 Amount

  • CIMP has a Yearly Dividend Yield of 9.29%, which is a nice return.
  • CIMP's Dividend Yield is slightly below the industry average, which is at 11.50.
  • Compared to an average S&P500 Dividend Yield of 1.89, CIMP pays a better dividend.
Industry RankSector Rank
Dividend Yield 9.29%

5.2 History

  • The dividend of CIMP decreases each year by -14.90%.
  • CIMP does not have a reliable dividend history as it only pays dividend since a couple or years.
Dividend Growth(5Y)-14.9%
Div Incr YearsN/A
Div Non Decr YearsN/A

5.3 Sustainability

  • CIMP pays out 144.48% of its income as dividend. This is not a sustainable payout ratio.
DP144.48%
EPS Next 2Y12.76%
EPS Next 3YN/A
CIMP Yearly Income VS Free CF VS DividendCIMP Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 200M -200M 400M -400M
CIMP Dividend Payout.CIMP Dividend Payout, showing the Payout Ratio.CIMP Dividend Payout.PayoutRetained Earnings

More info and screens

Find the best dividend stocksShow peers with best dividend

CIMP Fundamentals: All Metrics, Ratios and Statistics

CHIMERA INVESTMENT CORP - CIM 8 7/8 08/15/30

NYSE:CIMP (3/13/2026, 8:16:23 PM)

24.88

-0.1 (-0.4%)

Chartmill FA Rating
GICS SectorFinancials
GICS IndustryGroupFinancial Services
GICS IndustryMortgage Real Estate Investment Trusts (REITs)"
Earnings (Last)02-11
Earnings (Next)05-06
Inst Owners57.89%
Inst Owner ChangeN/A
Ins Owners1.84%
Ins Owner ChangeN/A
Market Cap2.07B
Revenue(TTM)798.15M
Net Income(TTM)144.47M
Analysts71.11
Price Target28.8 (15.76%)
Short Float %0.02%
Short Ratio0.48
Dividend
Industry RankSector Rank
Dividend Yield 9.29%
Yearly Dividend2.54
Dividend Growth(5Y)-14.9%
DP144.48%
Div Incr YearsN/A
Div Non Decr YearsN/A
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)-8.51%
Min EPS beat(2)-20.93%
Max EPS beat(2)3.91%
EPS beat(4)1
Avg EPS beat(4)-11.97%
Min EPS beat(4)-20.93%
Max EPS beat(4)3.91%
EPS beat(8)1
Avg EPS beat(8)-16.68%
EPS beat(12)1
Avg EPS beat(12)-19.66%
EPS beat(16)2
Avg EPS beat(16)-18.35%
Revenue beat(2)0
Avg Revenue beat(2)-27.4%
Min Revenue beat(2)-30.7%
Max Revenue beat(2)-24.11%
Revenue beat(4)0
Avg Revenue beat(4)-21.02%
Min Revenue beat(4)-30.7%
Max Revenue beat(4)-9.79%
Revenue beat(8)4
Avg Revenue beat(8)67.56%
Revenue beat(12)8
Avg Revenue beat(12)86.97%
Revenue beat(16)12
Avg Revenue beat(16)75.93%
PT rev (1m)-3.7%
PT rev (3m)-4.88%
EPS NQ rev (1m)-1%
EPS NQ rev (3m)-3.88%
EPS NY rev (1m)-4.2%
EPS NY rev (3m)-6.28%
Revenue NQ rev (1m)-4.79%
Revenue NQ rev (3m)-4.79%
Revenue NY rev (1m)-9.67%
Revenue NY rev (3m)-5.95%
Valuation
Industry RankSector Rank
PE 14.64
Fwd PE 12.23
P/S 2.6
P/FCF N/A
P/OCF N/A
P/B 0.81
P/tB 0.81
EV/EBITDA 67.08
EPS(TTM)1.7
EY6.83%
EPS(NY)2.04
Fwd EY8.18%
FCF(TTM)-3.44
FCFYN/A
OCF(TTM)-2.98
OCFYN/A
SpS9.57
BVpS30.85
TBVpS30.85
PEG (NY)0.74
PEG (5Y)N/A
Graham Number34.35
Profitability
Industry RankSector Rank
ROA 0.91%
ROE 5.62%
ROCE 1.48%
ROIC 0.68%
ROICexc 0.69%
ROICexgc 0.72%
OM 15.62%
PM (TTM) 18.1%
GM 31.43%
FCFM N/A
ROA(3y)0.67%
ROA(5y)0.3%
ROE(3y)3.75%
ROE(5y)1.04%
ROIC(3y)0.82%
ROIC(5y)1.32%
ROICexc(3y)0.83%
ROICexc(5y)1.35%
ROICexgc(3y)0.84%
ROICexgc(5y)1.36%
ROCE(3y)1.46%
ROCE(5y)2.25%
ROICexgc growth 3Y-20.75%
ROICexgc growth 5Y-22.9%
ROICexc growth 3Y-21.28%
ROICexc growth 5Y-23.3%
OM growth 3Y-22.61%
OM growth 5Y-19.82%
PM growth 3YN/A
PM growth 5Y70.35%
GM growth 3Y-12.54%
GM growth 5Y-10.18%
F-Score5
Asset Turnover0.05
Health
Industry RankSector Rank
Debt/Equity 4.62
Debt/FCF N/A
Debt/EBITDA 90.08
Cap/Depr 532.1%
Cap/Sales 4.79%
Interest Coverage 0.23
Cash Conversion N/A
Profit Quality N/A
Current Ratio 0.05
Quick Ratio 0.05
Altman-Z -0.54
F-Score5
WACC5.03%
ROIC/WACC0.14
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)16.44%
EPS 3Y-19.34%
EPS 5Y-17.8%
EPS Q2Q%43.24%
EPS Next Y19.71%
EPS Next 2Y12.76%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)5.61%
Revenue growth 3Y4.64%
Revenue growth 5Y-7.79%
Sales Q2Q%-65.33%
Revenue Next Year15.32%
Revenue Next 2Y9.33%
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-17.21%
EBIT growth 3Y-19.02%
EBIT growth 5Y-26.07%
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-239.59%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-221.01%
OCF growth 3YN/A
OCF growth 5YN/A

CHIMERA INVESTMENT CORP - CIM 8 7/8 08/15/30 / CIMP Fundamental Analysis FAQ

Can you provide the ChartMill fundamental rating for CHIMERA INVESTMENT CORP - CIM 8 7/8 08/15/30?

ChartMill assigns a fundamental rating of 3 / 10 to CIMP.


Can you provide the valuation status for CHIMERA INVESTMENT CORP - CIM 8 7/8 08/15/30?

ChartMill assigns a valuation rating of 4 / 10 to CHIMERA INVESTMENT CORP - CIM 8 7/8 08/15/30 (CIMP). This can be considered as Fairly Valued.


Can you provide the profitability details for CHIMERA INVESTMENT CORP - CIM 8 7/8 08/15/30?

CHIMERA INVESTMENT CORP - CIM 8 7/8 08/15/30 (CIMP) has a profitability rating of 4 / 10.


Can you provide the PE and PB ratios for CIMP stock?

The Price/Earnings (PE) ratio for CHIMERA INVESTMENT CORP - CIM 8 7/8 08/15/30 (CIMP) is 14.64 and the Price/Book (PB) ratio is 0.81.


Can you provide the dividend sustainability for CIMP stock?

The dividend rating of CHIMERA INVESTMENT CORP - CIM 8 7/8 08/15/30 (CIMP) is 3 / 10 and the dividend payout ratio is 144.48%.